Regulatory oversight gap identified in 21% of Argentine pharmaceutical laboratories

Data reveals that 51 of 235 ANMAT-authorized pharmaceutical facilities have evaded inspection for over five years. The extent of potential non-compliance or safety risks remains unquantified, highlighting a significant lapse in national health regulatory enforcement.